{
    "organizations": [],
    "uuid": "003fd7d6830d071caad34ed0f153af5dd3a06633",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-aeterna-zentaris-enters-licensing/brief-aeterna-zentaris-enters-licensing-agreement-with-strongbridge-for-macrilen-in-u-s-canada-idUSFWN1PC0YF",
    "ord_in_thread": 0,
    "title": "BRIEF-Aeterna Zentaris Enters Licensing Agreement With Strongbridge For Macrilen In U.S., Canada",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 17 (Reuters) - Aeterna Zentaris Inc:\n* AETERNA ZENTARIS ENTERS INTO LICENSING AND ASSIGNMENT AGREEMENT WITH STRONGBRIDGE FOR MACRILEN™ (MACIMORELIN) IN THE U.S. AND CANADA\n* AETERNA ZENTARIS INC - ‍THROUGH SUBSIDIARY, ENTERED LICENSE AND ASSIGNMENT AGREEMENT WITH SUBSIDIARY OF STRONGBRIDGE BIOPHARMA ​\n* AETERNA ZENTARIS INC - ‍ FOR AS LONG AS MACRILEN IS PATENT-PROTECTED, CO TO BE ENTITLED TO A 15 PERCENT ROYALTY ON NET SALES UP TO US$75 MILLION\n* AETERNA ZENTARIS INC - ‍ FOR AS LONG AS MACRILEN IS PATENT-PROTECTED, CO TO BE ENTITLED TO A 18 PERCENT ROYALTY ON NET SALES OVER US$75 MILLION\n* AETERNA ZENTARIS - ‍COMMITTEE WITH OVERSIGHT OF PEDIATRIC DEVELOPMENT PGM TO BE MADE OF 4 PERSONS,2 OF WHOM TO BE APPOINTED BY EACH OF STRONGBRIDGE, CO Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-17T20:47:00.000+02:00",
    "crawled": "2018-01-18T16:09:00.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "aeterna",
        "zentaris",
        "inc",
        "aeterna",
        "zentaris",
        "enters",
        "licensing",
        "assignment",
        "agreement",
        "strongbridge",
        "macimorelin",
        "canada",
        "aeterna",
        "zentaris",
        "inc",
        "subsidiary",
        "entered",
        "license",
        "assignment",
        "agreement",
        "subsidiary",
        "strongbridge",
        "biopharma",
        "aeterna",
        "zentaris",
        "inc",
        "long",
        "macrilen",
        "co",
        "entitled",
        "percent",
        "royalty",
        "net",
        "sale",
        "u",
        "million",
        "aeterna",
        "zentaris",
        "inc",
        "long",
        "macrilen",
        "co",
        "entitled",
        "percent",
        "royalty",
        "net",
        "sale",
        "u",
        "million",
        "aeterna",
        "zentaris",
        "oversight",
        "pediatric",
        "development",
        "pgm",
        "made",
        "appointed",
        "strongbridge",
        "co",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}